[go: up one dir, main page]

GB201504858D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB201504858D0
GB201504858D0 GBGB1504858.0A GB201504858A GB201504858D0 GB 201504858 D0 GB201504858 D0 GB 201504858D0 GB 201504858 A GB201504858 A GB 201504858A GB 201504858 D0 GB201504858 D0 GB 201504858D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1504858.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Priority to GBGB1504858.0A priority Critical patent/GB201504858D0/en
Publication of GB201504858D0 publication Critical patent/GB201504858D0/en
Priority to SG11201706292SA priority patent/SG11201706292SA/en
Priority to EP16704624.2A priority patent/EP3259285A2/en
Priority to JP2017561034A priority patent/JP6932649B2/en
Priority to KR1020177025612A priority patent/KR102672113B1/en
Priority to KR1020247018185A priority patent/KR20240091253A/en
Priority to EP20212421.0A priority patent/EP3878861B1/en
Priority to ES20212421T priority patent/ES3035137T3/en
Priority to EP25174127.8A priority patent/EP4592311A2/en
Priority to CN201680010400.8A priority patent/CN107207582A/en
Priority to US15/550,903 priority patent/US10953106B2/en
Priority to SG10202006863YA priority patent/SG10202006863YA/en
Priority to PCT/EP2016/053162 priority patent/WO2016131769A2/en
Priority to US17/019,537 priority patent/US11833222B2/en
Priority to JP2021132251A priority patent/JP7439024B2/en
Ceased legal-status Critical Current

Links

GBGB1504858.0A 2015-02-16 2015-03-23 Antibodies Ceased GB201504858D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1504858.0A GB201504858D0 (en) 2015-03-23 2015-03-23 Antibodies
PCT/EP2016/053162 WO2016131769A2 (en) 2015-02-16 2016-02-15 Antibodies
EP20212421.0A EP3878861B1 (en) 2015-02-16 2016-02-15 Cl and/or ch1 mutated antibodies for drug conjugation
EP25174127.8A EP4592311A2 (en) 2015-02-16 2016-02-15 Antibodies
JP2017561034A JP6932649B2 (en) 2015-02-16 2016-02-15 Antibodies for drug conjugation with mutated CL and / or CH1
KR1020177025612A KR102672113B1 (en) 2015-02-16 2016-02-15 Antibodies for CL and/or CH1 mutated drug conjugation
KR1020247018185A KR20240091253A (en) 2015-02-16 2016-02-15 Cl and/or ch1 mutated antibodies for drug conjugation
SG11201706292SA SG11201706292SA (en) 2015-02-16 2016-02-15 Cl and/or ch1 mutated antibodies for drug conjugation
ES20212421T ES3035137T3 (en) 2015-02-16 2016-02-15 Cl and/or ch1 mutated antibodies for drug conjugation
EP16704624.2A EP3259285A2 (en) 2015-02-16 2016-02-15 Cl and/or ch1 mutated antibodies for drug conjugation
CN201680010400.8A CN107207582A (en) 2015-02-16 2016-02-15 CL and/or CH1 mutant antibodies for drug conjugate
US15/550,903 US10953106B2 (en) 2015-02-16 2016-02-15 Antibodies
SG10202006863YA SG10202006863YA (en) 2015-02-16 2016-02-15 Cl and/or ch1 mutated antibodies for drug conjugation
US17/019,537 US11833222B2 (en) 2015-02-16 2020-09-14 CL and/or CH1 mutated antibodies for drug conjugation
JP2021132251A JP7439024B2 (en) 2015-02-16 2021-08-16 Antibodies for drug conjugation in which CL and/or CH1 are mutated

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1504858.0A GB201504858D0 (en) 2015-03-23 2015-03-23 Antibodies

Publications (1)

Publication Number Publication Date
GB201504858D0 true GB201504858D0 (en) 2015-05-06

Family

ID=53052224

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1504858.0A Ceased GB201504858D0 (en) 2015-02-16 2015-03-23 Antibodies

Country Status (1)

Country Link
GB (1) GB201504858D0 (en)

Similar Documents

Publication Publication Date Title
IL259048A (en) Anti-ror1 antibodies
ZA201708128B (en) Tau-binding antibodies
SG10201913864RA (en) Anti-LAG-3 Antibodies
ZA201705663B (en) Anti-transthyretin antibodies
LT3354729T (en) Anti-garp antibody
ZA201800027B (en) Tau-binding antibodies
GB201521393D0 (en) Antibodies
GB201521391D0 (en) Antibodies
SG11201706126WA (en) Anti-transthyretin antibodies
GB201521382D0 (en) Antibodies
IL255323A0 (en) Anti-fcrn antibodies
ZA201705662B (en) Anti-transthyretin antibodies
IL268889A (en) Anti-epha4 antibody
GB201600871D0 (en) Antibody
PT3336185T (en) Antibody
GB201509907D0 (en) Antibodies
GB201522394D0 (en) Antibodies
GB201503438D0 (en) Antibodies
IL284022B1 (en) Anti-transthyretin antibodies
GB201518728D0 (en) Antibodies
GB201515572D0 (en) Anti-LAG-3 antibodies
GB201515570D0 (en) Anti-LAG-3 antibodies
GB201514425D0 (en) Antibodies
GB201508437D0 (en) Antibodies
GB201508444D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)